Workshop on biosimilars

EventCorporateBiosimilars

Maltese is available via eTranslation, the European Commission's machine translation service.

Translate to Maltese | Important information about machine translation

Data

Thursday, 31 October 2013, All day

Post

European Medicines Agency, Amsterdam, the Netherlands

The workshop is intended to discuss the draft guideline on similar biological medical products, the draft guideline on similar biological medical products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues, and the draft guideline on similar biological medical products containing biotechnology-derived proteins as active substance: quality issues. Registration closed.

Documents

Agenda - Workshop on biosimilars

Reference Number: EMA/473908/2013

English (EN) (74.69 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

List of participants - Workshop on biosimilars

Reference Number: EMA/681299/2013

English (EN) (143.9 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - Draft revised guideline on similar biological medicinal products: Relevant changes (Martina Weise)

English (EN) (234.06 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - EBG’s comments on the draft revised guideline on similar biological medicinal products (Karl Heinz Emmert)

English (EN) (1.09 MB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - Guideline on similar biological medicinal products: Overarching guideline

English (EN) (734.59 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - Guideline on similar biological medicinal products containing biotechnologically-derived proteins as active substances: quality issues (Niklas Ekman)

English (EN) (159.22 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - EGA’s perspective on the draft quality guideline (Joerg Windisch)

English (EN) (922.36 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substances: Quality issues

English (EN) (656.89 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (Niklas Ekman)

English (EN) (309.73 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues (Hans-Karl Heim)

English (EN) (117.28 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - Guideline on Similar biological medicinal products containing biotechnology-derived proteins as active substance: Non-clinical and clinical issues (Pekka Kurki)

English (EN) (360.9 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - EBG’s perspective on the draft guideline on the non-clinical/clinical issues (Mark McCamish)

English (EN) (1.18 MB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Presentation - Nonclinical and clinical considerations

English (EN) (571.74 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Multimedia

Share this page